Fig. S1

Aug 13, 2014

10 likes | 139 Views

a) GLM without Q matrix. b) GLM with Q matrix. a) MLM without Q matrix ( K -only). b) MLM with Q matrix ( Q + K ). Fig. S1.

Share Presentation

Embed Code

Link

q matrix

myrrh

Download Presentation

Fig. S1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

a) GLM without Q matrix b) GLM with Q matrix a) MLM without Q matrix (K-only) b) MLM with Q matrix (Q+K) Fig. S1

Fig S1

Overexpression of Ezh2 correlates with higher tumor proliferation and aggressiveness in malignant lymphomas Virchows Archiv

238 views • 5 slides

Fig. S1

Fig. S1. Fig. S1 Representative histologic image of CCl 4 -induced cirrhotic liver. Azan-Mallory staining; original magnification x50. Fig. S2. Cirrhosis. Normal. IL-1 b. IL-8. TNF- a. TGF- b. PRL21. Fig. S2 Cytokine expression levels in the liver of ci rrhotic rats.

180 views • 2 slides

Fig. S1

a. b. 2.5. 7. 6. 2.0. 5. 1.5. 4. c ell mortality ratio (%). r elative cell number. 3. 1.0. 2. 0 .5. 1. 0. 0. CN 0.1 0.5 1 5 10 20 30. Sal ( m M ). CN 0.1 0.5 1 5 10 20 30. Sal ( m M ). c. 8. **. 6. Alizarin red S staining

169 views • 4 slides

Fig S1

Fig S1.

140 views • 3 slides

Fig S1

Fig S1. A). B). pET-opTAL. pET -TAL. M 3 4. kDa. kDa. M 1 2. 95. 95. 72. 72. 55. TAL. opTAL. 55. 43. 43. *. 34. 34. Fig S2. A). B). pET-opT5. pET-T5. M 3 4. M 1 2. kDa. kDa. 95. 95. 72. 72. Sam5(59kDa). Sam5 (59kDa). 55.

166 views • 4 slides

Fig S1

Fig S1. b. a. Cortex. Cortex. 20. 20. *. 16. 16. *. 12. 12. MAGL (fmol/mg/min). FAAH (fmol/mg/min). *. 8. 8. *. 0 mg/kg. *. 4. 4. 0 mg/kg. 1 mg/kg. 1 mg/kg. 0. 0. 0 1h 1d 2d 3d 10d. 0 1h 1d 2d 3d 10d. Time relative to injection.

178 views • 6 slides

Fig. S1

a. b. Highways. 0. 20. 40. Other roads. Urban area. Kilometers. Fig. S1. 0. 0. 0. 0. 0. 0. 0. 0. 20. 20. 20. 20. 20. 20. 20. 20. 40. 40. 40. 40. 40. 40. 40. 40. Kilometers. Kilometers. Kilometers. Kilometers. Kilometers. Kilometers. Kilometers. Kilometers.

180 views • 5 slides

Fig. S1

Fig. S1. A. B. C. D. Fig. S2. A. B. C. D. Fig. S3. E. A. C. D. B.

151 views • 3 slides

Fig. S1

3.74%. 3.54%. 45.60%. 41.22%. 3.54%. 3.74%. 47.21%. 43.34%. 4.35%. 5.15%. 2.01%. 3.00%. 4.35%. 5.15%. 33.84%. 34.73%. ROS dye added after trypsinization. ROS dye added before trypsinization. Percentage of ethidium fluorescence positive cells (O 2 .- production). Control. No GP.

255 views • 11 slides

Fig S1

Figure S1: 5T4 expression in B cell development . Adapted from microarray data published online by van Zelm et al http://franklin.et.tudelft.nl/#bcell [11]. Fig S1. (i). (ii). (ii). C. Figure S2 Expression of 5T4 by B-ALL relapse patients blasts

226 views • 7 slides

Fig. S1 :

Fig. S1 :.

141 views • 2 slides

Fig. S1

Fig. S1. WT Tg. Hsp90 Hsp70/72 HSPA12B * Hsp60 Hsp25  BC  -Tubulin. HSPA12B. PCAM-1. Merge. HSPA12B. PCAM-1. Merge. Fig.S2A. Fig.S2B. WT Tg. Baseline. 1 week post-sham. 4 weeks post-sham. Fig. S3. WT Tg. Fig. S4.

259 views • 11 slides

Fig. S1

Si. Mg. Ca. S. Fe. A. B. Fig. S1. Fig. S2. a. 10 m. b. S. Mg. O. Na. Si. 1.0. 2.0. 3.0. 4.0. 5.0. 6.0. 7.0. 8.0. keV. 9.0. Fig. S3. Fig. S4.

146 views • 4 slides

Fig. S1

A. cyc8∆ tup1∆ WT gcn4∆. h. c. GCN4-HA. h. c. GCN4-HA. h. c. GCN4-HA. vector. vector. vector. vector. myc-Spt7p. Gcd6p. B. cyc8∆ tup1∆ WT gcn4∆. h. c. GCN4-HA. h. c.

151 views • 1 slides

Fig. S1

Fig. S1. Fig. S2 a). Fig. S2 b).

190 views • 3 slides

Fig. S1

Fig. S1. 0,4. 0,2. 0. -0,2. RIS. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. -1,6. Strains. 0,4. 0,2. 0. -0,2. ALE. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. Strains. 0,4. 0,2. 0. -0,2. IBA. -0,4. Growth Rate. -0,6. -0,8. -1. -1,2. -1,4. Strains.

120 views • 4 slides

[Fig. S1]

[Fig. S1]. S 1 2 3 4 5 6 7 8 9. S 1. KDa. KDa. 250. 200. 150. 116. 100. 97. 75. (A). (B). 66. 50. 45. 37. 25. 20.

93 views • 1 slides

Fig. S1

Fig. S1. A. B. **. Relative total length. Relative total length. **. *. *. control. 100ng/ml. 200ng/ml. 400ng/ml. HDFNs. HUVECs. HDFNs. HUVECs. CM. Transwell. TIMP-1. C. D. **. Relative total length. Relative total length. **. control. Con siRNA. TIMP-1 siRNA.

124 views • 3 slides